256.35 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Johnson & Johnson
JNJNYSE • USD
257.30
↗ 0.95 (0.37%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
257.30
↗ 0.95 (0.37%)
Market: CLOSED
Johnson & Johnson (JNJ) trades at $257.79 per share. Technical and fundamental signals align bullish — technicals rate "Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score, exceptional Return on Equity (24.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 31, 2026.
Open?$256.01
High?$258.48
Low?$253.29
Prev. Close?$256.35
Volume?6.8M
Avg. Volume?8.9M
VWAP?$256.58
Rel. Volume?0.76x
Bid / Ask
Bid?$256.00 × 100
Ask?$258.10 × 300
Spread?$2.10
Midpoint?$257.05
Valuation & Ratios
Market Cap?617.8B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?29.37
P/B Ratio?7.27
EPS?$8.73
Dividend?2.04%
Ex-Dividend?2026-08-25
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
617.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?69
Short Sent.?57
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.33Safe
Confidence?73%Moderate
Short InterestModerate
Short % of Float?1.14%Low
Short Interest?27.4M
Days to Cover?3.7
Free Float2.4B
Avg Daily Volume7.5M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.37Low
Debt/Equity?0.58Moderate
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score61/100
P/E?29.4FAIR▾
Peers63
S&P35
P/B?7.27FAIR▾
Peers38
S&P26
P/S?6.31FAIR▾
Peers50
S&P20
P/FCF?27.8FAIR▾
Peers43
S&P33
EV/EBITDA?19.1FAIR▾
Peers56
S&P29
EV/Sales?6.60HIGH▾
Peers50
S&P23
Returns & Efficiency
ROE?24.8%STRONG▾
Peers63
S&P74
ROA?10.5%STRONG▾
Peers75
S&P76
Cash Flow & Enterprise
FCF?$22.2B
Enterprise Value?$646.4B
Fundamentals ratios updated end of day